DICE Therapeutics, Inc.
DICE Therapeutics, Inc.（DICE）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · DICE · 截至 2026年6月9日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
13
近12个月
买卖比
0.54
Buy/Sell (by trades)
整体情绪
DICE Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
DICE 季度内部人买卖趋势
DICE 内幕交易卖出 · DICE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
DICE 高管卖出股份 · DICE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 9, 2023 | RA CAPITAL MANAGEMENT, L.P. | Other | 786,407 | $79 | Form 4 |
| Aug 9, 2023 | TETLOW SHARON Director | Other | 49,841 | $5 | Form 4 |
| Aug 9, 2023 | Scopa James Paul Director | Other | 25,722 | $3 | Form 4 |
| Aug 9, 2023 | Robertson Scott M. CFO & CBO | Other | 198,000 | $20 | Form 4 |
| Aug 9, 2023 | SCHELLER RICHARD H Director | Other | 8,427 | $1 | Form 4 |
| Aug 9, 2023 | Timothy Lu CMO | Other | 152,285 | $15 | Form 4 |
| Aug 9, 2023 | Judice Kevin CEO · Director | Other | 799,685 | $80 | Form 4 |
| Aug 9, 2023 | Jacobsen John R. CSO | Other | 147,497 | $15 | Form 4 |
| Aug 2, 2023 | Scopa James Paul Director | Gift | 220 | — | Form 4 |
| Aug 2, 2023 | Scopa James Paul Director | Gift | 2,200 | — | Form 4 |
| Jul 18, 2023 | Scopa James Paul Director | Gift | 2,200 | — | Form 4 |
| Jul 11, 2023 | Scopa James Paul Director | Gift | 300 | — | Form 4 |
| Jun 22, 2023 | Northpond Ventures GP, LLC 10 percent owner | Sale | 1,969,368 | $91.58M⚡ | Form 4 |
| Jun 22, 2023 | Northpond Ventures GP, LLC 10 percent owner | Sale | 523,503 | $24.34M⚡ | Form 4 |
| Jun 1, 2023 | Jacobsen John R. CSO | Sale | 14,307 | $434K | Form 4 |
| Jun 1, 2023 | Jacobsen John R. CSO | Sale | 4,443 | $139K | Form 4 |
| May 5, 2023 | SCHELLER RICHARD H Director | Sale | 84,097 | $3.24M⚡ | Form 4 |
| May 3, 2023 | Robertson Scott M. CFO & CBO | Sale | 18,750 | $685K | Form 4 |
| May 3, 2023 | Timothy Lu CMO | Sale | 10,000 | $365K | Form 4 |
| May 3, 2023 | Judice Kevin CEO · Director | Sale | 13,698 | $500K | Form 4 |
| May 1, 2023 | Scopa James Paul Director | Gift | 6,923 | — | Form 4 |
| May 1, 2023 | Scopa James Paul Director | Gift | 6,923 | — | Form 4 |
| Apr 18, 2023 | Jacobsen John R. CSO | Sale | 16,392 | $493K | Form 4 |
| Mar 31, 2023 | Jacobsen John R. CSO | Sale | 773 | $23K | Form 4 |
| Mar 30, 2023 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | 195,997 | $5.63M⚡ | Form 4 |
Northpond Ventures GP, LLC
10 percent owner
日期
Jun 22
股数
1,969,368
均价
$46.50
总金额
$91.58M ⚡
Northpond Ventures GP, LLC
10 percent owner
日期
Jun 22
股数
523,503
均价
$46.50
总金额
$24.34M ⚡
RA CAPITAL MANAGEMENT, L.P.
Director
日期
Mar 30
股数
195,997
均价
$28.74
总金额
$5.63M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 DICE 内幕交易
DICE 内幕交易
DICE Therapeutics, Inc.（DICE）内幕交易数据来源于公司内部人（包括DICE）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。DICE内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看DICE Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
DICE 内幕交易 · 5个问题DICE Therapeutics, Inc.（DICE）的内部人包括高管和董事，如DICE等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026